跳至主要内容
临床试验/NCT07798232
NCT07798232尚未招募3 期

Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children

Children's Hospital Medical Center, Cincinnati1 个研究点 分布在 1 个国家目标入组 9,622 人开始时间: 2027年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
入组人数
9,622
试验地点
1
主要终点
Cumulative Incidence of Rheumatic Heart Disease

研究概览

简要总结

This study will look at whether children ages 5-8 who take Penicillin V by mouth twice a day are less likely to develop rheumatic heart disease (RHD) over a 3-year period compared to children who do not take the medicine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
5 Years 至 8 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 5-8 years at enrollment
  • Residence within the participating study catchment area (Gulu District or Gulu City)
  • Normal study echocardiogram confirmed by the expert adjudication panel
  • Parent/guardian able and willing to provide written informed consent
  • Participant able to provide written assent (age 8 years)

排除标准

  • History of prior ARF or RHD with or without cardiac involvement
  • Evidence of RHD on baseline echocardiography
  • Congenital heart disease (excluding small PFO, small ASD) or other cardiac abnormality at baseline echocardiography
  • Self-reported known allergy to penicillin
  • Medical conditions that would preclude safe participation, adherence, or follow-up
  • Anticipated inability to complete 36 months of study follow-up
  • Any known co-morbid condition requiring regular antibiotic prophylaxis

研究组 & 干预措施

No Prophylaxis

No Intervention

Oral Penicillin V

Active Comparator

干预措施: Oral Penicillin V (Drug)

结局指标

主要结局

Cumulative Incidence of Rheumatic Heart Disease

时间窗: 3 years

Proportion of participants with newly diagnosed RHD based on blinded echocardiographic adjudication among children with a normal baseline echocardiogram.

次要结局

  • Cumulative Incidence of RHD at One Year(1 year)
  • Number of Participants who Develop Acute Rheumatic Fever(3 years)
  • Cumulative Incidence of RHD at Two Years(2 years)
  • Number of Participants who Develop Early RHD(3 years)
  • Number of Participants who Develop Advanced RHD(3 years)
  • Number of Participants Experiencing Treatment-Emergent Adverse Events(3 years)
  • Number of Participants Achieving at least 80% Adherence to Oral Penicillin V Prophylaxis(3 years)
  • Number of Participants Achieving at least 80% Adherence to Oral Penicillin V Prophylaxis Based on Pill Count(3 years)
  • Number of Participants Achieving at Least 80% Adherence to Oral Penicillin V Prophylaxis Based on DoseSmart® Bottle Opening Records(3 years)
  • Number of Participants Achieving at Least 80% Adherence to Oral Penicillin V Prophylaxis Based on Caregiver-Reported Dosing Diary(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验